The Wistar Institute press release
PHILADELPHIA, Feb. 3, 2026 — Scientists at The Wistar Institute have developed an HIV vaccine candidate that achieves something never before observed in the field: inducing neutralizing antibodies against HIV after a single immunization in nonhuman primates. The innovative approach, published in Nature Immunology, could significantly shorten and simplify HIV vaccination protocols, making them more accessible worldwide.
The research centers on an engineered HIV envelope protein, WIN332, that challenges scientific assumptions about how to design an effective HIV vaccine.
Read the full press release here.
Source : The Wistar Institute
Related HIV and Co-Infections News
-
[Press release] Weizmann Institute of Science: Gut microbes actively support immunity in people living with HIV
-
[Press release] University of Cologne: HIV antibody opens up new approaches for vaccine development and combination therapies
-
[Press release] Salk Institute: How do nature and nurture shape our immune cells?
Get involved
Are you living with HIV/AIDS? Are you part of a community affected by HIV/AIDS and co-infections? Do you work or volunteer in the field? Are you motivated by our cause and interested to support our work?
Subscribe
Stay in the loop and get all the important EATG updates in your inbox with the EATG newsletter. The HIV & co-infections bulletin is your source of handpicked news from the field arriving regularly to your inbox.